Neurogen Limited
11116331
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/03/2025
total exemption full
Next accounts due
31/12/2026
Confirmation statement
Last: 05/12/2025
Due 19/12/2026
Industry
Officers
director · Since 18/12/2017
BUSINESS MANAGER
BRITISH · WALES · Age 40
Also on 2 other boards
director · Since 18/12/2017
SALES MANAGER
BRITISH · WALES · Age 40
Also on 1 other board
Persons with Significant Control
Dr Robert Michael David Goulding
British · Wales · Age 40
4 Castleton Court, Fortran Road, Cardiff, CF3 0LT
Notified 18/12/2017
Dr Rhodri Owain Lloyd
British · Wales · Age 40
4 Castleton Court, Fortran Road, Cardiff, CF3 0LT
Notified 18/12/2017
CompanyRankvs 8200+ SIC 86900 peers74
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£398k
Balance sheet strength
Cash
£316k
Cash in the bank
Net Current Assets
£296k
Working capital
Current Assets
£966k
Current Liabilities
£670k
Fixed Assets
£106k
Debtors
£590k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 1.44 | -£134k |
| 2024 | 1.82 | +£238k |
| 2023 | 2.60 | -£1k |
| 2022 | 1.97 | +£79k |
| 2021 | 2.64 | +£72k |
| 2020 | 2.81 | — |
Derived from filed accounts. Not audited figures.